The present invention relates to the use of a gene transfer product to reduce hyperplastic connective tissue growth after tissue trauma or implantation of a medical device.

• 本发明涉及基因转移产物在降低组织损伤或移植医疗装置后的增生性结缔组织生长中的用途。